S&P 500   3,331.95 (-0.59%)
DOW   27,393.29 (-0.69%)
QQQ   276.44 (-0.27%)
AAPL   113.85 (-0.97%)
MSFT   207.30 (-1.02%)
FB   258.77 (+0.76%)
GOOGL   1,455.98 (-0.18%)
AMZN   3,160.87 (-0.42%)
TSLA   423.86 (+0.63%)
NVDA   529.14 (+1.48%)
BABA   276.77 (+0.28%)
CGC   14.53 (+2.25%)
MU   50.70 (+1.97%)
GE   6.07 (-2.10%)
AMD   81.76 (+2.87%)
T   28.16 (-0.78%)
F   6.57 (-1.79%)
ACB   4.82 (+0.84%)
GILD   61.97 (-1.40%)
NFLX   493.03 (+0.49%)
DIS   123.90 (-1.66%)
BA   163.10 (-1.79%)
BAC   23.63 (-1.91%)
S&P 500   3,331.95 (-0.59%)
DOW   27,393.29 (-0.69%)
QQQ   276.44 (-0.27%)
AAPL   113.85 (-0.97%)
MSFT   207.30 (-1.02%)
FB   258.77 (+0.76%)
GOOGL   1,455.98 (-0.18%)
AMZN   3,160.87 (-0.42%)
TSLA   423.86 (+0.63%)
NVDA   529.14 (+1.48%)
BABA   276.77 (+0.28%)
CGC   14.53 (+2.25%)
MU   50.70 (+1.97%)
GE   6.07 (-2.10%)
AMD   81.76 (+2.87%)
T   28.16 (-0.78%)
F   6.57 (-1.79%)
ACB   4.82 (+0.84%)
GILD   61.97 (-1.40%)
NFLX   493.03 (+0.49%)
DIS   123.90 (-1.66%)
BA   163.10 (-1.79%)
BAC   23.63 (-1.91%)
S&P 500   3,331.95 (-0.59%)
DOW   27,393.29 (-0.69%)
QQQ   276.44 (-0.27%)
AAPL   113.85 (-0.97%)
MSFT   207.30 (-1.02%)
FB   258.77 (+0.76%)
GOOGL   1,455.98 (-0.18%)
AMZN   3,160.87 (-0.42%)
TSLA   423.86 (+0.63%)
NVDA   529.14 (+1.48%)
BABA   276.77 (+0.28%)
CGC   14.53 (+2.25%)
MU   50.70 (+1.97%)
GE   6.07 (-2.10%)
AMD   81.76 (+2.87%)
T   28.16 (-0.78%)
F   6.57 (-1.79%)
ACB   4.82 (+0.84%)
GILD   61.97 (-1.40%)
NFLX   493.03 (+0.49%)
DIS   123.90 (-1.66%)
BA   163.10 (-1.79%)
BAC   23.63 (-1.91%)
S&P 500   3,331.95 (-0.59%)
DOW   27,393.29 (-0.69%)
QQQ   276.44 (-0.27%)
AAPL   113.85 (-0.97%)
MSFT   207.30 (-1.02%)
FB   258.77 (+0.76%)
GOOGL   1,455.98 (-0.18%)
AMZN   3,160.87 (-0.42%)
TSLA   423.86 (+0.63%)
NVDA   529.14 (+1.48%)
BABA   276.77 (+0.28%)
CGC   14.53 (+2.25%)
MU   50.70 (+1.97%)
GE   6.07 (-2.10%)
AMD   81.76 (+2.87%)
T   28.16 (-0.78%)
F   6.57 (-1.79%)
ACB   4.82 (+0.84%)
GILD   61.97 (-1.40%)
NFLX   493.03 (+0.49%)
DIS   123.90 (-1.66%)
BA   163.10 (-1.79%)
BAC   23.63 (-1.91%)
Log in
NASDAQ:IRWD

Ironwood Pharmaceuticals SEC Filings & 10K Form

$9.23
-0.30 (-3.15 %)
(As of 09/29/2020 01:08 PM ET)
Add
Compare
Today's Range
$6.51
Now: $9.23▼
$9.25
50-Day Range
$9.45
MA: $9.99▼
$10.74
52-Week Range
$7.91
Now: $9.23▼
$14.10
Volume273,383 shs
Average Volume1.94 million shs
Market Capitalization$1.48 billion
P/E Ratio15.13
Dividend YieldN/A
Beta1.47

SEC Filings

Ironwood Pharmaceuticals (NASDAQ:IRWD) SEC Filings

DateFilerForm TypeView
09/29/2020
6:18 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
3:12 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
5:26 PM		Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
3:05 PM		Ironwood Pharmaceuticals (Issuer)
Rickard Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
3:01 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:05 PM		Ironwood Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
6:10 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2020
4:49 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:32 PM		Ironwood Pharmaceuticals (Issuer)
OLANOFF LAWRENCE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:39 PM		Ironwood Pharmaceuticals (Issuer)
Owens Edward P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:37 PM		Ironwood Pharmaceuticals (Issuer)
OLANOFF LAWRENCE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:36 PM		Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:35 PM		Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:34 PM		Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:33 PM		Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:32 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:23 PM		Ironwood Pharmaceuticals (Issuer)
Rickard Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:22 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:21 PM		Ironwood Pharmaceuticals (Issuer)
Mallon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:20 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:19 PM		Ironwood Pharmaceuticals (Issuer)
Kilroy Conor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
4:27 PM		Ironwood Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/16/2020
5:16 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
3:31 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:29 PM		Ironwood Pharmaceuticals (Issuer)
Mallon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:28 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
3:37 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:14 PM		Ironwood Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
02/13/2020
3:21 PM		Ironwood Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2020
6:05 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:02 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:43 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
4:23 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
7:31 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
3:38 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:37 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:36 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:34 PM		Gilbert Halley E (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:33 PM		Consylman Gina (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
5:26 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
5:23 PM		Consylman Gina (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2019
3:07 PM		Ironwood Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
6:06 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
7:00 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
4:12 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
3:53 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
8:10 AM		BROWN CAPITAL MANAGEMENT LLC (Filed by)
Ironwood Pharmaceuticals (Subject)
Form SC 13G/A
09/04/2019
3:42 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
4:37 PM		Consylman Gina (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
4:20 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:22 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
4:17 PM		Ironwood Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2019
3:48 PM		Gilbert Halley E (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2019
3:05 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
3:04 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:06 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
3:05 PM		Ironwood Pharmaceuticals (Issuer)
MacDonald Kelly (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2019
3:00 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
3:16 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:37 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
12:14 PM		Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
06/07/2019
3:06 PM		Ironwood Pharmaceuticals (Issuer)
OLANOFF LAWRENCE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:05 PM		Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:27 PM		Ironwood Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/31/2019
4:23 PM		Ironwood Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/31/2019
3:18 PM		Ironwood Pharmaceuticals (Issuer)
Owens Edward P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:09 PM		Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:08 PM		Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:05 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:05 PM		Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:04 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
3:52 PM		Ironwood Pharmaceuticals (Subject)
Sarissa Capital Management LP (Filed by)
Form SC 13D
05/14/2019
3:13 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
3:12 PM		Gilbert Halley E (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
3:10 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
3:08 PM		Consylman Gina (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:00 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:19 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:45 AM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:19 PM		Ironwood Pharmaceuticals (Filer)
Form DEF 14A
04/26/2019
2:10 PM		Ironwood Pharmaceuticals (Filer)
Form CT ORDER
04/12/2019
4:15 PM		Ironwood Pharmaceuticals (Filer)
Form PRE 14A
04/08/2019
3:45 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:46 PM		Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2019
6:06 PM		Ironwood Pharmaceuticals (Issuer)
Mallon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:46 PM		Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:44 PM		Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
5:42 PM		Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:37 PM		Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
5:36 PM		Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:34 PM		Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2019
5:17 PM		Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:15 PM		Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:13 PM		Gilbert Halley E (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:11 PM		Consylman Gina (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:10 PM		Huyett William (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:08 PM		Hecht Peter M (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:07 PM		Ironwood Pharmaceuticals (Issuer)
WILLIAMS DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:05 PM		Ironwood Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:04 PM		Ironwood Pharmaceuticals (Issuer)
MCGUIRE TERRANCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.